Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Working Capital Raise

23 Dec 2015 13:00

RNS Number : 0644K
Fitbug Holdings PLC
23 December 2015
 

 

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

23 December 2015

FITBUG HOLDINGS PLC ('FITBUG' OR 'THE COMPANY')

FURTHER WORKING CAPITAL RAISE

 

Fitbug Holdings Plc, the AIM quoted provider of online personal health and wellbeing services, is pleased to announce that it has raised a total of £650,000 by way of a further loan from NW1 Investments. The new loan is repayable by 31 July 2017, in line with the Group's other loans from NW1 and will accrue interest at a rate of 2.5% per annum above the base lending rate of the Bank of England from time to time payable quarterly in arrears. The Company intends to use the funds for near term working capital purposes, in particular for the growth of the recently launched Kiqplan Version 2.

 

Chief Executive Anna Gudmundson said: "NW1 advanced these further funds as they are pleased with the progress which the Group has made since the fundraising in August 2015. The Group has recruited some very talented people and has launched Version 2 of Kiqplan in line with the Board's expectations and laying the foundations on which to build our digital business. I am looking forward to growing our digital business significantly in 2016."

 

**ENDS**

 

For further information visit www.kiqplan.com or www.fitbugholdings.com contact:

 

 

Donald Stewart/ Anna Gudmundson

 

Fitbug Holdings Plc

020 7449 1000

Marc Milmo/ Catherine Leftley

Cantor Fitzgerald Europe, Nomad and Joint Broker

 

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

 

Hybridan LLP, Joint Broker

0203 713 4581/4582/4583

Elisabeth Cowell / Charlotte Heap

St Brides Partners Ltd, Public Relations

020 7236 1177

 

Notes

About Fitbug®

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people get fitter, lighter and lead happier, healthier lives.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug or Kiqplan into their own service/product offerings or resell to their customer base. The Company has operations in the UK and United States. For more information, visit www.fitbug.com and www.kiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTJBTTMBATBJA
Date   Source Headline
5th Oct 20224:35 pmRNS£10m Placing/Subscription ABB & Rex Retail Offer
21st Sep 20224:40 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20222:05 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:21 amRNSRevised Market Forecasts
20th Sep 20227:03 amRNSBidstack Expands US Operation with CRO Hire
20th Sep 20227:00 amRNSStrategy for Accelerated Growth in the US
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
31st Aug 20223:50 pmRNSNew IAB Intrinsic In-Game Measurement Standards
17th Aug 20227:00 amRNSSports Interactive, exclusive multi-year renewal
8th Aug 20227:00 amRNSInterim Results - six months ended 30 June 2022
11th Jul 20227:00 amRNSAsia-Pacific enterprise software deal
7th Jul 20224:40 pmRNSSecond Price Monitoring Extn
7th Jul 20224:35 pmRNSPrice Monitoring Extension
7th Jul 20227:00 amRNSTrading Update
17th Jun 20227:00 amRNSAppointment of Chairman Designate
24th May 202211:03 amRNS2022 AGM Results
23rd May 20227:00 amRNSHolding in Company
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSBidstack adds four games from Highbrow Interactive
28th Apr 20225:15 pmRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSBidstack Expands Portfolio With New Partnership
27th Apr 20227:00 amRNSFinal Results
8th Apr 202211:05 amRNSSecond Price Monitoring Extn
8th Apr 202211:00 amRNSPrice Monitoring Extension
24th Mar 20224:41 pmRNSSecond Price Monitoring Extn
24th Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 202211:05 amRNSSecond Price Monitoring Extn
21st Mar 202211:00 amRNSPrice Monitoring Extension
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
9th Mar 20229:00 amRNSPrice Monitoring Extension
9th Mar 20227:00 amRNSBidstack partners with GroupM’s Xaxis
3rd Mar 20228:00 amRNSBidstack partners farm simulation game Goodville
25th Feb 20224:40 pmRNSSecond Price Monitoring Extn
25th Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20227:00 amRNSBidstack adds 3 new titles from Game Tap Studios
8th Feb 20227:00 amRNSAppointment of CTO/CPO
24th Jan 20222:06 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSChange of Registered Office
10th Jan 20229:00 amRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
6th Jan 202211:06 amRNSSecond Price Monitoring Extn
6th Jan 202211:00 amRNSPrice Monitoring Extension
22nd Dec 20217:00 amRNSAdoption and Grant of LTIP Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.